PrEP for HIV Prevention: Evidence, Global Scale-up, and Emerging Options
Cell Host & Microbe, ISSN: 1931-3128, Vol: 27, Issue: 4, Page: 502-506
2020
- 38Citations
- 83Captures
- 3Mentions
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations38
- Citation Indexes38
- 38
- CrossRef26
- Captures83
- Readers83
- 83
- Mentions3
- News Mentions3
- 3
Most Recent News
Gates Foundation gives $122M for Univ. of Washington study on monthly HIV pill
Researchers at the University of Washington will test a once-a-month pill to prevent HIV in women with a new $122 million grant from the Bill
Article Description
Antiretroviral pre-exposure prophylaxis (PrEP) for the prevention of HIV infection was demonstrated to be efficacious and safe earlier this decade from pivotal studies using oral emtricitabine-tenofovir disoproxil fumarate. Regulatory approval and normative guidance, now for almost 70 countries worldwide, has followed. Demonstration projects have shown high uptake and population-level HIV reductions, highlighting the need for simplifying delivery and reducing current barriers to access and persistence. A portfolio of additional, next-generation PrEP formulations, currently under testing, if effective, will offer users choice and likely increase coverage and impact.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S1931312820301840; http://dx.doi.org/10.1016/j.chom.2020.03.020; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85082872914&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/32272075; https://linkinghub.elsevier.com/retrieve/pii/S1931312820301840; https://dx.doi.org/10.1016/j.chom.2020.03.020; https://www.cell.com/cell-host-microbe/fulltext/S1931-3128(20)30184-0; http://www.cell.com/article/S1931312820301840/abstract; http://www.cell.com/article/S1931312820301840/fulltext; http://www.cell.com/article/S1931312820301840/pdf; https://www.cell.com/cell-host-microbe/abstract/S1931-3128(20)30184-0; https://www.cell.com/cell-host-microbe/fulltext/S1931-3128(20)30184-0?dgcid=raven_jbs_etoc_email; https://www.cell.com/cell-host-microbe/fulltext/S1931-3128(20)30184-0?rss=yes; https://www.cell.com/cell-host-microbe/fulltext/S1931-3128(20)30184-0?utm_content=127944531&utm_medium=social&utm_source=twitter&hss_channel=tw-18477428
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know